Skip to main content
2024 Midyear Clinical Meeting & Exhibition Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Certified Pharmacy Executive Leader
Certified Pharmacy Executive Leader
Digital Health & Informatics
Digital Health & Informatics
Diversity, Equity and Inclusion
Diversity, Equity and Inclusion
Health & Wellness
Health & Wellness
Opioids & Pain Management
Opioids & Pain Management
Sterile Compounding
Sterile Compounding
Back
Handout Recording

Educational Sessions

Improving Precision of Anticoagulant Transition Strategies Through Anticoagulation Stewardship

Wednesday, December 11, 2024
2:00 PM – 3:15 PM  
Location: MCCNO, Room 267, Level 2
CE Credits: 1.25 contact hours
Activity #: 0204-0000-24-335-L01-P
Activity Type: Application-based
Target Audience: Pharmacist

Learning Objectives:

  • Evaluate the challenges associated with transitioning hospitalized patients from direct oral to parenteral anticoagulation.
  • Differentiate heparin anti-Xa levels and aPTT to manage unfractionated heparin infusions.
  • Analyze the correlation between heparin and low-molecular-weight heparin anti-Xa levels and oral factor Xa inhibitor concentrations.
  • Assess published literature on precision-based management of direct oral to parenteral anticoagulant transitions.
  • Design a precision-based treatment plan for direct oral to parenteral anticoagulant transitions given a patient case.